View Author
scopus: 6603852690

Guillon, C.

(Christophe Guillon)


virus coreceptor coreceptor usage usage clone infection hiv -2 antibody immunodeficiency virol receptor variant entry epitope antibody-mediated enhancement ccr 5 enhancement envelope patient strain protein replication chemokine table antibody-mediated xeno-gvhd 1996. glycoprotein interaction study phenotype disease number infectivity 87.cd cells #2.1 16.4 ficiency 1997. immunode disease progression osterhau guillon xeno-gvhd mice 2-1 gp 120 hiv -2 strains individual progression macrophage presence neutralization gruter domain cxcr -4 journal mouse tissue van der ende cxcr 4 usage v 3 loop t cells chemokine receptors xeno-gvhd symptoms pha-stimulated model virology 1998. chimera schutten hiv -2 infection 87.cd value expression capacity immunode ficiency virus hiv -2-infected individuals ccr -5-expressing cells contrast supt 1 cells




6 Most Recent Publications

Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in Nef. (Article)
Guillon, C. Boers, P.H.M. Verschuren, E.J. Gruters, R.A. Osterhaus, A.D.M.E. Baalen, C.A. van
2002-01-01
Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction (Article)
Guillon, C. Schutten, M. Boers, P.H.M. Gruters, R.A. Osterhaus, A.D.M.E.
2002-01-01
Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure. (Article)
Schutten, M. Baalen, C.A. van Guillon, C. Huisman, R.C. Boers, P.H.M. Sintnicolaas, K. Gruters, R.A. Osterhaus, A.D.M.E.
2001-03-13
Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model. (Article)
Ende, M.E. van der Guillon, C. Boers, P.H.M. Gruters, R.A. Racz, P. Tenner-Racz, K. Osterhaus, A.D.M.E. Schutten, M.
2000-01-01
Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities (Article)
Guillon, C. Boers, P.H.M. Gruters, R.A. Schutten, M. Ende, M.E. van der Osterhaus, A.D.M.E.
1998-01-01
Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities. (Article)
Guillon, C. Ende, M.E. van der Boers, P.H.M. Gruters, R.A. Schutten, M. Osterhaus, A.D.M.E.
1998-01-01